The company is responding to concerns about high levels of nitrosamines. Read More
Tags :Champix
Recent Posts
- No Significant Respiratory Symptoms Among Vapers: Study
- Pouch Nicotine Limits will Drive Users to Smoking: Tholos
- China Tobacco Deputy Head Expelled From Party
- Consumer Files Suit for Alleged Overcharging for Zyn
- Imperial Releases Full-Year Results
- New Surgeon General’s Report Addresses Disparities
- Kazakhstan Urged to Reconsider Policies
- IKE Tech, Ispire to File PMTA for Age Gating Technology
- Transition to Safer Products Underway: Report
- Thailand Launches Track-and-Trace System
- Tucker Carlson Launches Nicotine Pouch
- Marijuana More Popular in U.S. Than Cigarettes: Poll
- Robert Kennedy, Jr. Tapped to Lead Trump’s HHS
- Sweden Achieves ‘Smoke Free’ Status
- 22nd Century Net Loss Widens